Cash Flow Statement

Amortizatization of Intangibles Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Accured Expenses Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Receivables Depreciation & Amortization (CF)Free Cash Flow Gains from Investment Securities Net Cash Flow Net Income Other Working Capital Changes Sales of Property, Plant and Equipment Share-based Compensation

Daily Values

Growth Metrics

Others

Ratios

Day One Biopharmaceuticals (DAWN) Gains from Investment Securities: 2020-2024

Historic Gains from Investment Securities for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Dec 2024 value amounting to $2.6 million.